The fastest-growing and largest of the 41 sized OTC & Nutraceuticals markets in APAC, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Cannabidiol (CBD) Supplements | $1.1 Bn | $5.9 Bn | 18.1% | 20 |
| 2 | Prebiotics | $1.7 Bn | $5.8 Bn | 13.1% | 58 |
| 3 | Beauty Supplements | $861 Mn | $2.3 Bn | 10.5% | 37 |
| 4 | Coenzyme Q10 | $105 Mn | $279 Mn | 10.3% | 11 |
| 5 | Adaptogens | $1.7 Bn | $4.3 Bn | 9.8% | 25 |
| 6 | Mood and Stress Supplements | $2.2 Bn | $5.4 Bn | 9.4% | 9 |
| 7 | Plant-Based Supplements | $2.6 Bn | $6.3 Bn | 9.3% | 10 |
| 8 | Sports Nutrition | $10.9 Bn | $26.3 Bn | 9.2% | 19 |
| 9 | Herbal Supplements | $17.2 Bn | $40.3 Bn | 8.9% | 93 |
| 10 | Omega 3 Fatty Acid | $861 Mn | $2 Bn | 8.7% | 57 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Nutritional Supplements | $80.9 Bn | $175.7 Bn | 8.1% | 378 |
| 2 | Dietary Supplements | $64.7 Bn | $132.9 Bn | 7.5% | 437 |
| 3 | Functional Food | $59.9 Bn | $128.9 Bn | 8% | 298 |
| 4 | Over The Counter (OTC) Drugs | $37.4 Bn | $66.8 Bn | 6% | 33 |
| 5 | Over The Counter (OTC) Pharmaceuticals | $37.4 Bn | $66.8 Bn | 6% | 33 |
| 6 | Over The Counter (OTC) Consumer | $31.7 Bn | $59.4 Bn | 6.5% | 33 |
| 7 | Herbal Supplements | $17.2 Bn | $40.3 Bn | 8.9% | 93 |
| 8 | Sports Nutrition | $10.9 Bn | $26.3 Bn | 9.2% | 19 |
| 9 | Over The Counter (OTC) Vitamins and Minerals | $6.7 Bn | $12.9 Bn | 6.8% | 52 |
| 10 | Clinical Nutrition | $6 Bn | $13.4 Bn | 8.4% | 141 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running, in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand.
Cannabidiol (CBD) Supplements grows fastest, at 18.1% a year from 2023 to 2033, ahead of Prebiotics (13.1%).
Nutritional Supplements is the largest, worth about $80.9 Bn in 2023 and $175.7 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.